Clinical trial

G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant…

NCT00233961 · Herbert Irving Comprehensive Cancer Center, Other · Completed

Key facts

NCT number NCT00233961
Title G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission
Official title Peripheral Blood Stem Cell Mobilization With Filgrastim in Patients With Chronic Myeloid Leukemia in Cytogenetic Response
Lead sponsor Herbert Irving Comprehensive Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Leukemia
Intervention type Biological
Interventions filgrastim
Enrollment 20
Start date Jan 1, 2005
Primary completion Nov 1, 2007
Completion Jan 1, 2008
First posted Oct 6, 2005
Last update posted Feb 4, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies